Daniel Cervantes

Daniel Cervantes (dcerva@yahoo.com) is an assistant principal scientist with ARMGO Pharma, Tarrytown, New York, where he participates in the development of novel small molecules that normalize the function of ryanodine receptor calcium channels in a number of debilitating disorders.

Associated articles

IEEE PULSE, Retrospectroscope November/December 2016
Nikola Tesla
La vita percorre sempre; mentre noi spesso ci diventiamo cose quasi perduti nel mezzo del camin. [Life keeps going on; in the meantime, we often become things almost lost in the middle of the road]. —Max E. Valentinuzzi Jeden Tag denke ich unzählige... Read more